Aastrom to acquire Sanofi's cell therapy and regenerative medicine business
Aastrom announced an agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine business for $6.5 million, with $4 million payable in cash at closing and $2.5 million payable in the form of a promissory note. April 21, 2014